The table below shows Caribou Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$26.98M
-$36.73M
-$37.20M
-$27.94M
-$21.67M
$20.31M
Capital expenditure
$72.00K
$1.04M
$1.45M
$2.03M
$723.00K
$22.00K
Investing cash flow
$23.98M
$49.38M
$22.96M
$20.70M
-$72.11M
-$22.00K
Dividends paid
-
-
-
-
CRBU operating cash flow (10-K history)
Caribou Biosciences, Inc. reported operating cash flow of -$110.99M for fiscal year 2025. That is up 19.7% from -$138.20M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$32.01M (FY 2019) to -$110.99M. Figures come from the company's audited annual reports as filed with the SEC.